Germline variants predictive of tumor mutational burden and immune checkpoint inhibitor efficacy

High tumor mutational burden (TMB) is associated with response to checkpoint blockade in several cancers. We identify pathogenic germline variants associated with increased TMB (GVITMB). GVITMB were found in 7 genes using a pan-cancer approach (APC, FANCL, SLC25A13, ERCC3, MSH6, PMS2, and TP53) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatrath, Ajay, Ratan, Aakrosh, Dutta, Anindya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988326/
https://www.ncbi.nlm.nih.gov/pubmed/33786423
http://dx.doi.org/10.1016/j.isci.2021.102248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988326/
https://www.ncbi.nlm.nih.gov/pubmed/33786423
http://dx.doi.org/10.1016/j.isci.2021.102248

Ejemplares similares